Study the correlation between alleles of MCT1 gene and enduring performance in handball players
Keywords:
Alleles of MCT1 gene, Enduring performance, Handball playersAbstract
The current study aimed to determine MCT1 gene A1470T polymorphism is associated it with enduring performance among elite handball players young. The community of study was chosen 100 young players of Iraqi clubs in handball game which their length (171.83 ± 3.060 cm), weight (68.33 ± 2.160 kg) and age (24.4 ± 3.782 years). Genotyping of A1470T polymorphism of the MCT1 gene was done by the PCR-RFLP technique lactate measurement of 100 handball players was examined after testing the endurance of defensive and attack performance. Frequencies of genotypes in 100 players were AA genotype (60%), AT genotype (30%) and TT genotype (10%).The mean of endurance capacity was significantly higher in AA genotype (1.01 ± 0.04 min) versus AT genotype (1.10 ± 0.01 min). (AA + AT) genotypes versus TT genotype (1.14 ± 0.01 min). Mean of blood lactate concentration was significantly higher in AA genotype (16.23 ± 0.35 mMol) versus (AT + TT) genotypes (13.48 ± 0.18; 11.66 ± 0.13 mMol) respectively. We concluded that the MCT1 gene A1470T polymorphism enhances enduring performance in elite handball players.
Downloads
References
Abo-Alola,A. &Ahmad ,N.A.(2003).Fitness physiology.cairo,Dar Al-fakar Al-Arabi,p.277.
Abo Al-Ouala,A.(2003).Training and sport physiology.cairo,Al-fakar al arabi.ed1,p.294.
Al-haggar, M.; Eid, A.; Ramadan,W.; D Abdel-hady,D.; and Hassan,R.(2017).MCT1 polymorphism among Egyptian children and adolescents as a useful predictor for physical fitness and muscle fatigue. J Syst Biol Proteome Res, Volume 1 Issue.
Allami,H.A.(2012)."The impact of Anaerobic Exercises and Phosphate creatine on Specal Endurance with Reference to Lactic Acid Concentration (CPK- L.D.H) of Al-Qadisiyah Governorate Youth Team of Handball" . Unpublished Ph.D. thesis. The college of sport education, University of AL-Qadisiyah. Iraq.
Bentley DJ, Roels B, Thomas C, et al.(2009). The relationship between monocarboxylate transporters 1 and 4 expression in skeletal muscle and endurance performance in athletes. Eur J Appl Physiol. 2009;106:465-471. https://doi.org/10.1007/s00421-009-1034-5
Calò,C. & Vona,G. (2008).Gene polymorphisms and elite athletic performance. Journal of Anthropological Sciences Vol. 86 , pp. 113-13.
Cupeiro R, Benito PJ, Maffulli N, Calderon FJ, Gonzalez-Lamuno D.(2010). MCT1 genetic polymorphism influence in high intensity circuit training: a pilot study. J Sci Med Sport; 13: 526-30. https://doi.org/10.1016/j.jsams.2009.07.004
Cupeiro R, Gonzalez-Lamuno D, Amigo T, (2012). Influence of the MCT1-T1470A polymorphism (rs1049434) on blood lactate accumulation during different circuit weight trainings in men and women. J Sci Med Sport.15:541-547. https://doi.org/10.1016/j.jsams.2012.03.009
Dubouchaud H, Butterfield GE, Wolfel EE, Bergman BC, Brooks GA.(2000). Endurance training, expression, and physiology of LDH, MCT1 and MCT4 in human skeletal muscle. Am J Physiol Endocrinol Metab;278. https://doi.org/10.1152/ajpendo.2000.278.4.E571
Fedotovskaya,O.; Mustafina,L.; Popov,D.;Vinogradova,O.; and Ahmetov,I.(2014). A Common Polymorphism of the MCT1 Gene and Athletic Performance. International Journal of Sports Physiology and Performance, 9, 173 -180. https://doi.org/10.1123/ijspp.2013-0026
Garcia CK, Li X, Luna J, .(1994). cDNA cloning of the human monocarboxylate transporter 1 and chromosomal localization of the SLC16A1 locus to 1p13. 2-p12.Genomics. 15; 23(2):500-3. https://doi.org/10.1006/geno.1994.1532
Halestrap AP.(2009). Monocarboxylate Transporter 1. UCSDNature Signaling Gateway Molecule Page. https://doi.org/10.1038/mp.a001490.01
Halestrap AP, Wilson MC.(2012). The monocarboxylate transporter family-role and regulation. IUBMB Life;64(2):109-119. https://doi.org/10.1002/iub.572
Kambouris M, Ntalouka F, Ziogas G, Maffulli N.(2012). Predictive Genomics DNA Profiling for Athletic Performance. Recent Pat DNA Gene ; 6:229-39. https://doi.org/10.2174/187221512802717321
Kobayashi M, Fujita I, Itagaki S, Hirano T, Iseki K.(2005). Transport mechanism for L-lactic acid in human myocytes using human prototypic embryonal rhabdomyosarcoma cell line (RD) cells. Biol Pharm Bull. ; 28 (7):1197-1201. https://doi.org/10.1248/bpb.28.1197
Maldonado S., Mujika L. & Padilla S. (2002). Influence of body mass and weight on the energy cost of running in highly trained middle- and long distance runners. Int. J. Sports Med., 23:268-272. https://doi.org/10.1055/s-2002-29083
Merezhinskaya N, Fishbein WN, Davis JI, et al.(2000). Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport. Muscle Nerve. 1; 23(1):90-7. https://doi.org/10.1002/(SICI)1097-4598(200001)23:1<90::AID-MUS12>3.0.CO;2-M
Mykkänen AK, Koho NM, Reeben M, et al.(2011).MCT1, MCT4 and CD147 gene polymorphisms in healthy horses and horses with myopathy. Res Vet Sci. 31; 91(3):473-7. https://doi.org/10.1016/j.rvsc.2010.09.025
Pilegaard H, Bangsbo J, Richter EA, et al.(1994). Lactate transport studied in sarcolemmal giant vesicles from human muscle biopsies: relation to training status. J Appl physiol. 1; 77(4):1858-62. https://doi.org/10.1152/jappl.1994.77.4.1858
Thomas C, Bishop DJ, Lambert K, et al.(2012). Effects of acute and chronic exercise on sarcolemmal MCT1 and MCT4 contents in human skeletal muscles: Current status. Am J Physiol Regul Integr Comp Physiol. 1; 302(1):R1-4. https://doi.org/10.1152/ajpregu.00250.2011
Vetter,RE.(2007). Effects of six wam-up protocols on sprint and jump performance.J .strength cond Res 21:819-823. https://doi.org/10.1519/00124278-200708000-00028
Wilson MC, Jackson VN, Heddle C, et al.(1998). Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter isoform MCT3. J Biol Chem. 26; 273(26):15920-6. https://doi.org/10.1074/jbc.273.26.15920
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Journal of Human Sport and Exercise
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Each author warrants that his or her submission to the Work is original and that he or she has full power to enter into this agreement. Neither this Work nor a similar work has been published elsewhere in any language nor shall be submitted for publication elsewhere while under consideration by JHSE. Each author also accepts that the JHSE will not be held legally responsible for any claims of compensation.
Authors wishing to include figures or text passages that have already been published elsewhere are required to obtain permission from the copyright holder(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Please include at the end of the acknowledgements a declaration that the experiments comply with the current laws of the country in which they were performed. The editors reserve the right to reject manuscripts that do not comply with the abovementioned requirements. The author(s) will be held responsible for false statements or failure to fulfill the above-mentioned requirements.
This title is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license (CC BY-NC-ND 4.0).
You are free to share, copy and redistribute the material in any medium or format. The licensor cannot revoke these freedoms as long as you follow the license terms under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
Transfer of Copyright
In consideration of JHSE’s publication of the Work, the authors hereby transfer, assign, and otherwise convey all copyright ownership worldwide, in all languages, and in all forms of media now or hereafter known, including electronic media such as CD-ROM, Internet, and Intranet, to JHSE. If JHSE should decide for any reason not to publish an author’s submission to the Work, JHSE shall give prompt notice of its decision to the corresponding author, this agreement shall terminate, and neither the author nor JHSE shall be under any further liability or obligation.
Each author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article, except as disclosed on a separate attachment. All funding sources supporting the Work and all institutional or corporate affiliations of the authors are acknowledged in a footnote in the Work.
Each author certifies that his or her institution has approved the protocol for any investigation involving humans or animals and that all experimentation was conducted in conformity with ethical and humane principles of research.
Competing Interests
Biomedical journals typically require authors and reviewers to declare if they have any competing interests with regard to their research.
JHSE require authors to agree to Copyright Notice as part of the submission process.
